Apollo Endosurgery, Inc.
Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $76.9M | $63.0M | $42.0M | $50.7M | $60.9M | $64.3M |
| Operating income | −$31.4M | −$19.2M | −$15.8M | −$23.5M | −$40.1M | −$22.4M |
| Net income | −$39.8M | −$24.7M | −$22.6M | −$27.4M | −$45.8M | −$27.3M |
| Total assets | $110.2M | $131.5M | $77.4M | $74.6M | $74.5M | $109.1M |
| Total liabilities | $77.6M | $70.3M | $70.7M | $72.5M | $45.6M | $59.1M |
| Equity | $32.6M | $61.2M | $6.8M | $2.1M | $28.8M | $49.9M |
| EPS (diluted) | $-0.98 | $-0.82 | $-0.99 | — | — | — |
| Shares out. | 39.6M | 26.0M | 21.1M | 21.9M | 17.3M | 10.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −40.9%
- Net margin
- −51.8%
- Return on equity
- −122.2%
- Return on assets
- −36.1%
- Return on capital (ROCE)
- −44.4%
- Liabilities / assets
- 70.4%
- Debt / equity
- 2.38×
- Book value / share
- $0.82
- Revenue growth (YoY)
- 22.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -8.28distress
- Accruals / assets
- −7.8%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 30, 2007
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2005
- NT 10-Qmissed a reporting deadline ↗Aug 16, 2004
- NT 10-Qmissed a reporting deadline ↗May 14, 2004
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Mcgaughy R Kent JrDirector | Apr 4, 2023 | D | 675,181 | — |
| Cpmg Inc10% owner | Apr 4, 2023 | D | 675,181 | — |
| Barr John RDirector | Apr 4, 2023 | D | 44,082 | — |
| Bankes JeannetteDirector | Apr 4, 2023 | D | 17,641 | — |
| O'Keefe SharonDirector | Apr 4, 2023 | D | 35,604 | — |
| Mckhann ChasOfficer — President and CEO | Apr 4, 2023 | D | 689,880 | — |
| Mcclellan William D. Jr.Director | Apr 4, 2023 | D | 39,249 | — |
| Molesphini John JOfficer — EVP, Operations | Apr 4, 2023 | D | 92,626 | — |
| Gostout Christopher J.Officer — Chief Medical Officer | Apr 4, 2023 | D | 90,267 | — |
| Gutteridge MikeOfficer — VP, Int'l Sales and Marketing | Apr 4, 2023 | D | 86,647 | — |
| Black Jeffrey G.Officer — Chief Financial Officer | Apr 4, 2023 | D | 335,330 | — |
| Shimer Julie AnnDirector | Apr 4, 2023 | D | 36,021 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 4, 2023
- Shareholder voteFeb 10, 2023
- Unregistered equity saleDec 29, 2022
- Other material eventDec 28, 2022
- Entered a material agreementNov 30, 2022
- Regulation FD disclosureNov 29, 2022
- Results of operationsNov 1, 2022
- Entered a material agreementOct 6, 2022
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.